The urinary tract infection testing devices market size has grown strongly in recent years. It will grow from $0.66 billion in 2025 to $0.71 billion in 2026 at a compound annual growth rate (CAGR) of 6.3%. The growth in the historic period can be attributed to high prevalence of UTIs, hospital diagnostic workload growth, routine urinalysis adoption, demand for faster diagnosis, expansion of diagnostic laboratories.
The urinary tract infection testing devices market size is expected to see strong growth in the next few years. It will grow to $0.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to point-of-care testing expansion, AI-assisted urine analysis, growth in home diagnostics, rising antimicrobial resistance concerns, rapid diagnostic kit innovation. Major trends in the forecast period include rapid point-of-care UTI testing, automated urinalysis systems, home-based UTI testing kits, improved bacterial detection accuracy, antibiotic susceptibility screening.
The increasing prevalence of urinary tract infections (UTIs) is expected to drive the growth of the urinary tract infection testing devices market. UTIs can affect any part of the urinary system, such as the kidneys, ureters, bladder, or urethra, and are commonly caused by bacteria, with Escherichia coli being the most frequent pathogen. The rise in UTI cases is attributed to factors such as prolonged catheter use, poor hygiene practices, and growing antimicrobial resistance among hospitalized patients. UTI testing devices assist in the rapid and accurate diagnosis of UTIs, enabling healthcare providers to identify the causative bacteria and administer targeted treatments quickly. This helps reduce complications, improve patient outcomes, and limit the spread of antimicrobial resistance within healthcare environments. According to the University of New South Wales, a public research university in Australia, UTIs are widespread, with over 400 million cases reported globally each year. As a result, the rising incidence of UTIs is fueling the demand for urinary tract infection testing devices.
Leading companies in the UTI testing devices market are focusing on developing point-of-care (POC) testing devices that offer quicker, more convenient diagnoses, improving patient care. POC testing allows medical diagnostics to be performed at or near the patient's location, such as at a doctor's office, hospital bedside, or even at home, without the need for laboratory sample processing. For example, in June 2023, Sysmex Corporation, a Japanese company, introduced the PA-100 AST System, a point-of-care testing system for detecting antimicrobial susceptibility. This system can identify bacterial presence in urine and assess the effectiveness of antimicrobials in under 30 minutes. It provides results on bacterial growth in about 10 minutes and offers susceptibility test outcomes in less than 30 minutes, enabling healthcare professionals to conduct rapid tests on patients suspected of having UTIs.
In August 2024, Alpha Laboratories Ltd., a UK-based diagnostics and laboratory supplies company, entered into a strategic partnership with Clinical Design Technologies Ltd. to market and support the UTS digital closed urine testing system, with the objective of transforming point-of-care urinalysis by enabling faster, more accurate results and improving clinical efficiency. Clinical Design Technologies Ltd. is a UK-based medical device company that developed the UTS (Urine Testing System), a digital closed urinalysis platform designed for rapid, point-of-care urine testing that streamlines clinical workflows and provides precise diagnostic data.
Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann‑La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, bioMérieux SA, Bio‑Rad Laboratories, QIAGEN NV, Sysmex Corporation, Quidel Corporation, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc., Cepheid, Meridian Bioscience Inc., Luminex Corporation, Beckman Coulter Inc., OraSure Technologies Inc., Mesa Biotech Inc.
North America was the largest region in the urinary tract infection testing devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urinary tract infection testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the urinary tract infection testing devices market by increasing costs of diagnostic reagents, sensors, and automated analyzer components. Instrument and kit segments are most affected, particularly in North America and Europe due to dependence on Asia-Pacific manufacturing. While tariffs have raised testing costs, they have also driven local kit production, streamlined reagent usage, and innovation in cost-effective rapid testing solutions.
The urinary tract infection testing devices market research report is one of a series of new reports that provides urinary tract infection testing devices market statistics, including urinary tract infection testing devices industry global market size, regional shares, competitors with a urinary tract infection testing devices market share, detailed urinary tract infection testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the urinary tract infection testing devices industry. This urinary tract infection testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Urinary tract infection (UTI) testing devices are medical instruments designed to diagnose infections in the urinary system by identifying bacteria, white blood cells, or other indicators in urine samples. These devices vary from simple dipsticks and culture kits to more sophisticated automated analyzers, offering fast and precise results that help guide treatment decisions.
The primary types of UTI testing devices include instruments and kits. UTI testing kits are popular for their convenience and affordability, making them commonly used in point-of-care environments and for self-testing. The different types of tests include urinalysis, urine cultures, and susceptibility testing, and they are utilized by various end-users such as hospitals, diagnostic laboratories, and other healthcare providers.
The urinary tract infection (UTI) testing devices market consists of sales of urine analyzers, dipsticks, and culture systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The urinary tract infection testing devices market size is expected to see strong growth in the next few years. It will grow to $0.9 billion in 2030 at a compound annual growth rate (CAGR) of 6.2%. The growth in the forecast period can be attributed to point-of-care testing expansion, AI-assisted urine analysis, growth in home diagnostics, rising antimicrobial resistance concerns, rapid diagnostic kit innovation. Major trends in the forecast period include rapid point-of-care UTI testing, automated urinalysis systems, home-based UTI testing kits, improved bacterial detection accuracy, antibiotic susceptibility screening.
The increasing prevalence of urinary tract infections (UTIs) is expected to drive the growth of the urinary tract infection testing devices market. UTIs can affect any part of the urinary system, such as the kidneys, ureters, bladder, or urethra, and are commonly caused by bacteria, with Escherichia coli being the most frequent pathogen. The rise in UTI cases is attributed to factors such as prolonged catheter use, poor hygiene practices, and growing antimicrobial resistance among hospitalized patients. UTI testing devices assist in the rapid and accurate diagnosis of UTIs, enabling healthcare providers to identify the causative bacteria and administer targeted treatments quickly. This helps reduce complications, improve patient outcomes, and limit the spread of antimicrobial resistance within healthcare environments. According to the University of New South Wales, a public research university in Australia, UTIs are widespread, with over 400 million cases reported globally each year. As a result, the rising incidence of UTIs is fueling the demand for urinary tract infection testing devices.
Leading companies in the UTI testing devices market are focusing on developing point-of-care (POC) testing devices that offer quicker, more convenient diagnoses, improving patient care. POC testing allows medical diagnostics to be performed at or near the patient's location, such as at a doctor's office, hospital bedside, or even at home, without the need for laboratory sample processing. For example, in June 2023, Sysmex Corporation, a Japanese company, introduced the PA-100 AST System, a point-of-care testing system for detecting antimicrobial susceptibility. This system can identify bacterial presence in urine and assess the effectiveness of antimicrobials in under 30 minutes. It provides results on bacterial growth in about 10 minutes and offers susceptibility test outcomes in less than 30 minutes, enabling healthcare professionals to conduct rapid tests on patients suspected of having UTIs.
In August 2024, Alpha Laboratories Ltd., a UK-based diagnostics and laboratory supplies company, entered into a strategic partnership with Clinical Design Technologies Ltd. to market and support the UTS digital closed urine testing system, with the objective of transforming point-of-care urinalysis by enabling faster, more accurate results and improving clinical efficiency. Clinical Design Technologies Ltd. is a UK-based medical device company that developed the UTS (Urine Testing System), a digital closed urinalysis platform designed for rapid, point-of-care urine testing that streamlines clinical workflows and provides precise diagnostic data.
Major companies operating in the urinary tract infection testing devices market are Cardinal Health Inc., F. Hoffmann‑La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthcare GmbH, bioMérieux SA, Bio‑Rad Laboratories, QIAGEN NV, Sysmex Corporation, Quidel Corporation, ACON Laboratories Inc., Randox Laboratories Ltd., ARKRAY Inc., T2 Biosystems Inc., Cepheid, Meridian Bioscience Inc., Luminex Corporation, Beckman Coulter Inc., OraSure Technologies Inc., Mesa Biotech Inc.
North America was the largest region in the urinary tract infection testing devices market in 2025. Asia Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the urinary tract infection testing devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the urinary tract infection testing devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are impacting the urinary tract infection testing devices market by increasing costs of diagnostic reagents, sensors, and automated analyzer components. Instrument and kit segments are most affected, particularly in North America and Europe due to dependence on Asia-Pacific manufacturing. While tariffs have raised testing costs, they have also driven local kit production, streamlined reagent usage, and innovation in cost-effective rapid testing solutions.
The urinary tract infection testing devices market research report is one of a series of new reports that provides urinary tract infection testing devices market statistics, including urinary tract infection testing devices industry global market size, regional shares, competitors with a urinary tract infection testing devices market share, detailed urinary tract infection testing devices market segments, market trends and opportunities, and any further data you may need to thrive in the urinary tract infection testing devices industry. This urinary tract infection testing devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Urinary tract infection (UTI) testing devices are medical instruments designed to diagnose infections in the urinary system by identifying bacteria, white blood cells, or other indicators in urine samples. These devices vary from simple dipsticks and culture kits to more sophisticated automated analyzers, offering fast and precise results that help guide treatment decisions.
The primary types of UTI testing devices include instruments and kits. UTI testing kits are popular for their convenience and affordability, making them commonly used in point-of-care environments and for self-testing. The different types of tests include urinalysis, urine cultures, and susceptibility testing, and they are utilized by various end-users such as hospitals, diagnostic laboratories, and other healthcare providers.
The urinary tract infection (UTI) testing devices market consists of sales of urine analyzers, dipsticks, and culture systems. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Urinary Tract Infection Testing Devices Market Characteristics
3. Urinary Tract Infection Testing Devices Market Supply Chain Analysis
4. Global Urinary Tract Infection Testing Devices Market Trends and Strategies
5. Urinary Tract Infection Testing Devices Market Analysis of End Use Industries
7. Global Urinary Tract Infection Testing Devices Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Urinary Tract Infection Testing Devices Total Addressable Market (TAM) Analysis for the Market
9. Urinary Tract Infection Testing Devices Market Segmentation
10. Urinary Tract Infection Testing Devices Market Regional and Country Analysis
11. Asia-Pacific Urinary Tract Infection Testing Devices Market
12. China Urinary Tract Infection Testing Devices Market
13. India Urinary Tract Infection Testing Devices Market
14. Japan Urinary Tract Infection Testing Devices Market
15. Australia Urinary Tract Infection Testing Devices Market
16. Indonesia Urinary Tract Infection Testing Devices Market
17. South Korea Urinary Tract Infection Testing Devices Market
18. Taiwan Urinary Tract Infection Testing Devices Market
19. South East Asia Urinary Tract Infection Testing Devices Market
20. Western Europe Urinary Tract Infection Testing Devices Market
21. UK Urinary Tract Infection Testing Devices Market
22. Germany Urinary Tract Infection Testing Devices Market
23. France Urinary Tract Infection Testing Devices Market
24. Italy Urinary Tract Infection Testing Devices Market
25. Spain Urinary Tract Infection Testing Devices Market
26. Eastern Europe Urinary Tract Infection Testing Devices Market
27. Russia Urinary Tract Infection Testing Devices Market
28. North America Urinary Tract Infection Testing Devices Market
29. USA Urinary Tract Infection Testing Devices Market
30. Canada Urinary Tract Infection Testing Devices Market
31. South America Urinary Tract Infection Testing Devices Market
32. Brazil Urinary Tract Infection Testing Devices Market
33. Middle East Urinary Tract Infection Testing Devices Market
34. Africa Urinary Tract Infection Testing Devices Market
36. Urinary Tract Infection Testing Devices Market Competitive Landscape and Company Profiles
37. Urinary Tract Infection Testing Devices Market Other Major and Innovative Companies
40. Urinary Tract Infection Testing Devices Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Urinary Tract Infection Testing Devices Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses urinary tract infection testing devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for urinary tract infection testing devices? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The urinary tract infection testing devices market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Product type: Instruments; Kits2) By Test Type: Urinalysis; Urine Cultures; Susceptibility Testing
3) By End-User: Hospitals; Diagnostic Labs; Other End Users
Subsegments:
1) By Instruments: Automated UTI Analyzers; UTI Culture Systems; UTI Microscopes; UTI Diagnostic Devices (Handheld Devices)2) By Kits: UTI Test Strips; UTI Reagents; Urine Culture Kits; UTI Home Testing Kits
Companies Mentioned: Cardinal Health Inc.; F. Hoffmann‑La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Siemens Healthcare GmbH; bioMérieux SA; Bio‑Rad Laboratories; QIAGEN NV; Sysmex Corporation; Quidel Corporation; ACON Laboratories Inc.; Randox Laboratories Ltd.; ARKRAY Inc.; T2 Biosystems Inc.; Cepheid; Meridian Bioscience Inc.; Luminex Corporation; Beckman Coulter Inc.; OraSure Technologies Inc.; Mesa Biotech Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Urinary Tract Infection Testing Devices market report include:- Cardinal Health Inc.
- F. Hoffmann‑La Roche Ltd.
- Thermo Fisher Scientific Inc.
- Abbott Laboratories
- Siemens Healthcare GmbH
- bioMérieux SA
- Bio‑Rad Laboratories
- QIAGEN NV
- Sysmex Corporation
- Quidel Corporation
- ACON Laboratories Inc.
- Randox Laboratories Ltd.
- ARKRAY Inc.
- T2 Biosystems Inc.
- Cepheid
- Meridian Bioscience Inc.
- Luminex Corporation
- Beckman Coulter Inc.
- OraSure Technologies Inc.
- Mesa Biotech Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 0.71 Billion |
| Forecasted Market Value ( USD | $ 0.9 Billion |
| Compound Annual Growth Rate | 6.2% |
| Regions Covered | Global |
| No. of Companies Mentioned | 21 |
